CMKM Diamonds Inc (fka CMKX) : JANICE Why would I be having issues wit...

JANICE Why would I be having issues with my

stockhound · 2004-09-15T04:15:47.3430000Z

JANICE Why would I be having issues with my shares of CMKX stock in my ETRADE account as well as others? The shares I bought at .0001 and .0002 are having issues so my broker put it. The shares I bought at .0003 and higher here lately are not having issues. What would be a good reason for that? The issue is that the older shares don't show up as assets in my account and I can't trade them online. The newer share lots purchased for .0003 or higher I can trade freely. I have to call the broker to try and trade the older share lots. Can you think of a good reason for this? They show up normally in my portfolio but when you check deeper into your accounts they are not credited.

Play Episode

8min

Proactive - Interviews for investors

Time Finance CEO on Q3 update: record lending & growth to resilient small businesses

Time Finance PLC (AIM:TIME) CEO Ed Rimmer takes Proactive's Stephen Gunnion through the company’s performance in the third quarter, highlighting a record gross lending book and improved arrears management. Rimmer explained that Time Finance provides funding solutions to small businesses, including invoice finance, asset finance, and secured loans, typically supporting businesses with turnover up to £10 million. He said, “We help businesses grow, but we also help businesses to survive as well.” The company’s lending book reached a record £210 million at the end of February, with arrears falling to 5% from 6% a year earlier. Rimmer noted this progress came despite challenging market conditions and was achieved without compromising credit quality. Margins have also increased, with profit margins now at 40%. This was attributed to tight cost control and improved efficiency, including leveraging technology and streamlining internal processes. Time Finance has not increased its headcount significantly post-COVID, which has helped support margin growth. Rimmer also addressed the broader economic environment, pointing to interest rate pressures, inflation, and increased insolvencies, but emphasised that small businesses remain resilient. The company sees opportunity as traditional banks become more risk-averse, creating space for independent lenders. Visit Proactive’s YouTube channel for more interviews like this. Don’t forget to like the video, subscribe to the channel, and enable notifications so you never miss an update. #TimeFinance #SMElending #AlternativeFinance #BusinessLoans #InvoiceFinance #AssetFinance #Q3TradingUpdate #IndependentLender #FinancialResults #SmallBusinessFinance

Proactive - Interviews for investors

Arc Minerals expands portfolio with acquisition of Chingola Copper Project in Zambia

Arc Minerals Limited (AIM:ARCM) executive chairman Nick von Schirnding and chief operating officer Vassilios Carellas joined Stephen Gunnion in the Proactive studio with details of the company’s latest acquisition—the Chingola Copper Project in Zambia. Von Schirnding highlighted that the project is located in the northeast of the Zambian Copper Belt, an area known for high-grade copper deposits. The site is less than 30km from major existing operations, including Vedanta’s Nchanga Mine and Moxico Resources’ Mimbula Mine. He described the acquisition as strategic, adding that Arc Minerals has been pursuing it for 18 months due to its high prospectivity. Carellas detailed the financial terms of the deal, explaining that Arc Minerals has committed an initial $75,000, with milestone-based payments tied to drilling and resource confirmation. He emphasised that the transaction is structured to limit financial risk, allowing the company to exit if exploration does not yield the expected results. Von Schirnding also reassured investors that the company’s upcoming exploration work at Chingola is fully funded, with soil sampling expected to commence soon. The project will add to Arc Minerals’ growing portfolio, which includes its joint venture with Anglo American in Zambia’s northwest and assets in Botswana. Carellas noted that Chingola’s geological potential remains largely untested in the last 20 years, making it a prime target for new exploration techniques. The company expects active news flow as soil sampling and drilling programs progress. Arc Minerals also provided updates on its joint venture with Anglo American, confirming that preparations are underway for drilling to commence soon. Stay tuned for more updates on Arc Minerals’ progress. Don’t forget to like this video, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest updates on mining and investment news. #ArcMinerals #CopperMining #Zambia #MiningInvestment #ChingolaProject #

Proactive - Interviews for investors

OKYO Pharma achieves key stability milestone for Urcosimod in clinical development

OKYO Pharma CEO Gary Jacob joined Steve Darling from Proactive to share a significant advancement in the company’s ongoing drug development efforts. The company has successfully demonstrated that urcosimod—formerly known as OK-101—remains stable for more than two and a half years in single-use ampoules, which are used for patient administration. This milestone is a crucial step forward in ensuring the long-term viability of the drug as it progresses through clinical trials. Urcosimod is currently being evaluated in a Phase 2b clinical trial, which is a randomized, placebo-controlled, double-masked study involving 48 patients. The trial is focused on assessing the drug’s effectiveness in treating neurotrophic keratopathy (NCP), a serious and progressive degenerative eye disease. Jacob emphasized that achieving success in clinical development extends beyond obtaining positive clinical trial data. A crucial aspect of regulatory approval includes meeting the rigorous Chemistry, Manufacturing, and Controls (CMC) requirements set by the U.S. Food and Drug Administration (FDA). By demonstrating long-term stability, OKYO Pharma has strengthened its regulatory submission package, addressing an essential factor in the drug’s future approval and commercialization. The company recently completed Good Manufacturing Practice (GMP) stability assay testing of single-use ampoules containing urcosimod in an ophthalmic solution. The results were highly promising—ampoules stored under refrigerated conditions maintained stability for over two and a half years, while initial three-month data from samples stored at room temperature showed potency levels at or above 100%. These findings reinforce confidence in urcosimod’s shelf life and its potential for real-world clinical use. As OKYO Pharma continues to advance urcosimod through the regulatory and clinical development process, this stability milestone represents a critical achievement in its journey toward providing an effective tr

Proactive - Interviews for investors

SSV Capital repays £2.5M early, eyes expansion

SSV Capital PLC CEO Ankur Ghosh talked with Proactive about the company’s early loan repayment, expansion in fintech and real estate, and upcoming plans for 2025. SSV Capital has made strides in solidifying its financial position, having repaid a £2.5 million convertible loan note ahead of schedule. Ghosh attributed the decision to strong investor trust and confidence in the company’s banking and fintech operations. “If our balance sheet is strong, why can’t we repay them early?” he stated, highlighting the company's proactive approach even in a challenging financial climate. Ghosh also discussed momentum behind SSV Smart Pay, noting positive reception from both merchants and customers and ambitious targets of scaling to 2 million transactions this year. The initiative incorporates loyalty and cashback schemes and is underpinned by open banking and upcoming embedded finance capabilities. In addition, SSV Capital is progressing in its Proptech development through its SSV Real Estate unit. Ghosh explained that the project has passed alpha and beta testing and is now on track to roll out in the coming months. Looking ahead, the company is focusing on institutional partnerships, establishing a presence as a general partner in Luxembourg, and pursuing FCA licenses as it builds out an equity desk focused on early-stage private equity and venture capital. Visit Proactive's YouTube channel for more insightful interviews and updates. Don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #SSVCapital #AnkurGhosh #SmartPay #Fintech #OpenBanking #EmbeddedFinance #RealEstateTech #Proptech #PrivateEquity #VentureCapital #FinancialServices #InstitutionalInvestment #InvestorUpdates #FCA #LuxembourgFunds

Followers	0
Posts	183
Boards Moderated	0
Alias Born	08/01/2004

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Go Ad-Free